Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
HHS
Court Orders HHS to Halt 340B-Specific Payment Rate
On September 28, 2022, the U.S. District Court for the District of Columbia ordered HHS to stop its 340B-specific payment rate and…
Biden Administration Provides Update on Opioid Crisis Funding
In late September 2022, United States President Joe Biden released a statement regarding what his administration has done to help…
HHS to Invest Nearly $60 Million in Rural Health Care Communities
Earlier this year, the United States Department of Health and Human Services (HHS) announced a nearly $60 million investment in…
HHS Issues Guidance on Audio-Only Telehealth
Earlier this year, the United States Department of Health and Human Services (HHS) issued guidance to explain how audio-only…
Third Interim Final Rule for No Surprises Act Now Published
On August 26, 2022, the U.S. Departments of Health and Human Services (HHS), Labor and the Treasury (the Departments) have issued…
MGMA Requests “Appropriate Implementation Timeline” for No Surprises Act
On August 2, 2022, the Medical Group Management Association (MGMA) sent a letter to Xavier Becerra, Secretary of the Department of…
HHS OIG Finds Inaccuracies and Limitations in Medicare Enrollment Data
Earlier this year, the Department of Health and Human Services’ Office of Inspector General (HHS OIG) released a report showing…
HHS Wants to Reinterpret the Affordable Care Act, Healthcare Discrimination
On August 4, 2022, the US Department of Health and Human Services (HHS) issued a Notice of Proposed Rulemaking to reinterpret…
Merck Sues HHS Over 340B Fines
The saga between the federal government and pharmaceutical companies over the 340B program continues to heat up. In July 2022,…
Attention on March-In Rights – What Are They and Why are they Relevant?
March-in rights are rights granted to the federal government, allowing the government the ability to grant patent licenses to…